Growth Hormone

Growth Hormone Research Peptides

The growth hormone category contains research peptides studied in pituitary axis research, growth hormone secretagogue receptor (GHSR) research, and growth hormone-releasing hormone (GHRH) pathway studies. These compounds are among the most-investigated peptides in endocrinology research literature.

Compounds in this category

• CJC-1295 — Synthetic GHRH analog. Available in DAC and non-DAC variants. The non-DAC version has a shorter half-life; the DAC (Drug Affinity Complex) version is modified for extended stability in solution.
• Ipamorelin — Selective growth hormone secretagogue. Pentapeptide structure with selective GHSR binding properties.
• Sermorelin — Synthetic 29-amino-acid GHRH analog representing the active fragment of natural GHRH.
• Tesamorelin — GHRH analog with extended pharmacokinetic profile compared to Sermorelin.
• CJC-1295 + Ipamorelin Blend — Combined research blend often used in research literature for studying complementary GHRH/GHSR pathway interactions.

Research applications

The compounds in this category are studied in: pituitary gland research, growth hormone secretion pathway studies, IGF-1 production research, somatostatin receptor interaction research, and metabolic research models. Research interest spans both isolated-compound studies and combination studies investigating GHRH analog plus secretagogue synergies.

Quality standards at VialPepLab

Every batch is HPLC-verified to ≥99% purity. LC-MS confirms molecular identity against theoretical mass calculated from the published sequence. Blend products (e.g., CJC-1295 + Ipamorelin) document both component purities separately on the COA. Lyophilized vials remain stable at -20 °C; reconstituted with bacteriostatic water, store at 2–8 °C and use within 14–28 days.

All compounds in this category are sold strictly for in-vitro laboratory research. Not for human or veterinary use.